Dyslipidemia Update
- PMID: 37536782
- DOI: 10.1016/j.cnur.2023.05.002
Dyslipidemia Update
Abstract
Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in the United States. The development and progression of atherosclerotic CVD are largely dependent on a multitude of modifiable and nonmodifiable risk factors. Current therapeutic strategies involve risk factor modification, especially dyslipidemia. The treatment of dyslipidemia continues to be dynamic, and in this paper, we review the current strategies for risk assessment, diagnosis, and treatment. As treatments for the management of dyslipidemia continue to evolve with ever-increasing options for therapeutic targets, an understanding of lipid-lowering therapies remains an essential topic of understanding for all health care providers.
Keywords: Cardiovascular risk reduction; Dyslipidemia; Hyperlipidemia.
Published by Elsevier Inc.
Similar articles
-
Recent advances and emerging therapies in management of dyslipidemias.Trends Cardiovasc Med. 2021 Oct;31(7):419-424. doi: 10.1016/j.tcm.2020.08.007. Epub 2020 Aug 25. Trends Cardiovasc Med. 2021. PMID: 32858149 Review.
-
Key Articles and Guidelines in the Management of Dyslipidemia: 2019 Update.J Pharm Pract. 2020 Dec;33(6):882-894. doi: 10.1177/0897190019868413. Epub 2019 Aug 11. J Pharm Pract. 2020. PMID: 31401932
-
Optimizing Dyslipidemia Management for the Prevention of Cardiovascular Disease: a Focus on Risk Assessment and Therapeutic Options.Curr Cardiol Rep. 2019 Aug 5;21(9):110. doi: 10.1007/s11886-019-1175-z. Curr Cardiol Rep. 2019. PMID: 31378838 Review.
-
Management of dyslipidemia as a cardiovascular risk factor in individuals with nonalcoholic fatty liver disease.Clin Gastroenterol Hepatol. 2014 Jul;12(7):1077-84; quiz e59-60. doi: 10.1016/j.cgh.2013.08.014. Epub 2013 Aug 17. Clin Gastroenterol Hepatol. 2014. PMID: 23962548 Free PMC article. Review.
-
Lipid-lowering therapy: who can benefit?Vasc Health Risk Manag. 2011;7:525-34. doi: 10.2147/VHRM.S23113. Epub 2011 Aug 24. Vasc Health Risk Manag. 2011. PMID: 21915170 Free PMC article. Review.
Cited by
-
Triglyceride-glucose index predicts all-cause mortality, but not cardiovascular mortality, in rural Northeast Chinese patients with metabolic syndrome: a community-based retrospective cohort study.Nutr Metab (Lond). 2024 May 21;21(1):27. doi: 10.1186/s12986-024-00804-0. Nutr Metab (Lond). 2024. PMID: 38773582 Free PMC article.
-
Cyp3A4 *1G polymorphism is associated with alcohol drinking: A 5-year retrospective single centered population-based study in China.PLoS One. 2023 Dec 20;18(12):e0295184. doi: 10.1371/journal.pone.0295184. eCollection 2023. PLoS One. 2023. PMID: 38117809 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials
